The purpose of this study is to determine if the Punctum Plug Delivery System (PPDS) is safe and effective in controlling intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
36
Control of IOP compared to baseline for the low dose of Latanoprost-PPDS for 4 months or until loss of efficacy
Control of IOP compared to baseline for the medium dose of Latanoprost-PPDS for 4 months or until loss of efficacy
Control of IOP compared to baseline for the high dose of Latanoprost-PPDS for 4 months or until loss of efficacy
Unnamed facility
Artesia, California, United States
Unnamed facility
Sacramento, California, United States
Unnamed facility
Bel Air, Maryland, United States
Unnamed facility
Minneapolis, Minnesota, United States
IOP change from baseline
Time frame: 12 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
St Louis, Missouri, United States
Unnamed facility
Lynbrook, New York, United States
Unnamed facility
High Point, North Carolina, United States
Unnamed facility
Philadelphia, Pennsylvania, United States